MeSH D053306 - hyper-igm immunodeficiency syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D004406:Dysgammaglobulinemia
0 Companies
0 Drugs
Success rate
D000081207:Primary immunodeficiency diseases
D030342:Inborn genetic diseases
D053306:
Hyper-igm immunodeficiency syndrome
0 Companies
0 Drugs
Success rate
D053307:Type 1 hyper-igm immunodeficiency syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/4
Phase 3
0%0/0
Approved: 0Overall Success rate: 0%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use